Indication

Metastatic colorectal cancer

Metastatic colorectal cancer refers to advanced, stage IV malignancy arising from the epithelial lining of the large intestine—either the colon or the rectum—that has disseminated beyond local regional structures. Read more about Metastatic colorectal cancer

114 drugs 78 manufacturers

Advertisement

Drugs that treat it

Common Metastatic colorectal cancer therapies.

Showing 73–81 of 114 drugs

IRINOTECAN HCL

ANTINEOPLASTIC - TOPOISOMERASE I INHIBITORS·METASTATIC COLORECTAL CANCER
Hikma Pharmaceuticals USA

OXALIPLATIN

METASTATIC COLORECTAL CANCER·+1
Actavis Pharma

CAPECITABINE

5 FLUOROPYRIMIDINES·MALIGNANT ESOPHAGEAL NEOPLASM·+7
ASCEND LABORATO

CAPECITABINE

5 FLUOROPYRIMIDINES·MALIGNANT ESOPHAGEAL NEOPLASM·+7
AUROBINDO PHARM

CAPECITABINE

5 FLUOROPYRIMIDINES·MALIGNANT ESOPHAGEAL NEOPLASM·+7
ARMAS PHARMACEU

OXALIPLATIN

PLATINUM COMPOUNDS·METASTATIC COLORECTAL CANCER·+1
FOSUN PHARMA US

MVASI (bevacizumab-awwb)

VASCULAR ENDOTHELIAL GROWTH FACTOR(VEGF) MONOCLONAL ANTIBODY·METASTATIC COLORECTAL CANCER·+5
AMGEN
Filter & compare in the drug finder →Opens the drug finder with Metastatic colorectal cancer preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Metastatic colorectal cancer.

Metastatic colorectal cancer refers to advanced, stage IV malignancy arising from the epithelial lining of the large intestine—either the colon or the rectum—that has disseminated beyond local regional structures.

Tumor cells spread hematogenously, via the lymphatic system, or through peritoneal seeding, most commonly establishing secondary lesions in the liver, lungs, distant lymph nodes, and peritoneum.

Clinically, affected patients may present with bowel obstruction, hematochezia, and cachexia, as well as organ-specific manifestations of distant spread such as hepatomegaly, jaundice, or dyspnea.

Pathophysiologically, the disease is driven by the progressive accumulation of genomic and epigenetic alterations, frequently involving mutations in key oncogenic drivers such as *KRAS*, *NRAS*, or *BRAF*, along with distinct microsatellite instability or mismatch repair statuses.

Personalize your experience

Follow Metastatic colorectal cancer and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it